Hims & Hers Health (HIMS) Financial Analysis & Valuation | Quarter Chart
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It als... more
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers ... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $6.23B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Equipment & Services |
| Country | US | CEO | Andrew Dudum |
| IPO Date | 2019-09-13 | CAGR | 74.71% |
| Employees | 2,442 | Website | www.forhims.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 18.71% | Total Yield | 18.71% |
HIMS chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $8.40B | P/E | -43.3 | Forward P/E | 37.59 | PEG | — |
| P/S | 0.25 | P/B | 1.93 | P/CF | 2.36 | P/FCF | 6.73 |
| Sales | $2.58B | Sales 1Y | 28.04% | Sales 3Y | 262.75% | Sales 5Y | 1216.73% |
| EPS | $-0.64 | EPS 1Y | -178.32% | EPS 3Y | 175.31% | EPS 5Y | 1.44% |
| Sales QoQ | 23.86% | EPS QoQ | -7.5% | Sales QoQ Avg | 8.84% | EPS QoQ Avg | -161.01% |
| Gross Margin | 64.68% | Operating Margin | -3.59% | Profit Margin | -5.51% | ROCE | -4.32% |
| ROA | -4% | ROE | -30% | Altman Z Score | 1.55 | Piotroski Score | 2 |
| Current Ratio | 0.93 | Quick Ratio | 0.87 | Cash Ratio | 0.41 | Op. CF Ratio | -0.02 |
| Debt/Equity | 4.77 | Debt/Assets | 0.43 | Lt Debt/Equity | 4.74 | Lt Debt/Cap. | 0.81 |
| Intrst Cov. | — | Inventory Turnover | 10.37 | Asset Turnover | 0.71 | Receivables Turnover | 6.87 |
| Enterprise Value | $8.40B | P/E Ratio | -43.3 |
| Forward P/E | 37.59 | PEG Ratio | — |
| P/S Ratio | 0.25 | P/B Ratio | 1.93 |
| P/CF Ratio | 2.36 | P/FCF Ratio | 6.73 |
| EPS | $-0.64 | EPS Growth 1Y | -178.32% |
| EPS Growth 3Y | 175.31% | EPS Growth 5Y | 1.44% |
| Revenue Growth 1Y | 28.04% | Gross Margin | 64.68% |
| Operating Margin | -3.59% | Profit Margin | -5.51% |
| ROE | -30% | ROA | -4% |
| ROCE | -4.32% | Current Ratio | 0.93 |
| Quick Ratio | 0.87 | Cash Ratio | 0.41 |
| Debt/Equity | 4.77 | Interest Coverage | — |
| Altman Z Score | 1.55 | Piotroski Score | 2 |
Hims & Hers Health (HIMS) valuation & financials
Hims & Hers Health (HIMS) has a market capitalization of $6.23B and trades at a price-to-earnings ratio of -43.3. It operates in the Healthcare sector (Medical - Equipment & Services).
Hims & Hers Health's revenue grew +28.0% over the last year.
Hims & Hers Health's next earnings report is scheduled for November 9, 2026 after market close (provider scheduled date); analysts estimate EPS of $0.06. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)